v3.26.1
Related Party Transactions - Additional Information (Details)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
USD ($)
shares
Jun. 30, 2026
USD ($)
Seats
shares
Jun. 30, 2025
USD ($)
Dec. 31, 2025
USD ($)
shares
Nov. 10, 2025
$ / shares
Related Party Transaction [Line Items]          
Stock-based compensation   $ 9,278 $ 351    
Common stock, issued | shares 61,734,601 61,734,601   1,597,321  
Sock-based compensation expense   $ 9,278 $ 351    
Paragon Agreement          
Related Party Transaction [Line Items]          
Related party transactions $ 10,300 27,300      
Stock-based compensation 4,500 9,500      
Sock-based compensation expense 4,500 9,500      
Unpaid amount 5,700 5,700      
Cash payments to related party transaction 12,100 29,300      
Related Party Transaction, Amounts of Transaction 10,300 $ 27,300      
Paramora Option Obligation          
Related Party Transaction [Line Items]          
Percentage of outstanding shares covered by annual equity grant of warrants   1.00%      
Exercise price per warrant | $ / shares         $ 23.01
Related Party          
Related Party Transaction [Line Items]          
Unpaid amount $ 5,662 $ 5,662   $ 17,221  
Related Party | Fairmount          
Related Party Transaction [Line Items]          
Related party transaction number of board seats | Seats   3      
Galecto, Inc. | Minimum | Capital Units | Related Party | Fairmount          
Related Party Transaction [Line Items]          
Ownership percentage 5.00% 5.00%      
Galecto, Inc. | Maximum | Common Stock | Related Party | Paragon Therapeutics, Inc. and Paramora Holding LLC          
Related Party Transaction [Line Items]          
Ownership percentage 5.00% 5.00%      
Paragon | Minimum | Related Party | Fairmount          
Related Party Transaction [Line Items]          
Ownership percentage 5.00% 5.00%      
Paragon License Agreement | Paragon Agreement          
Related Party Transaction [Line Items]          
Maximum Amount to be Paid Upon Achievement of Specific Development Regulatory and Clinical Milestones $ 22,000 $ 22,000      
Payments upon achievement of specific development, regulatory and clinical milestones 22,000 22,000      
Milestone payment $ 2,500 $ 2,500